Soleno Drug Patent Portfolio
Soleno owns 1 orange book drug protected by 6 US patents Given below is the list of Soleno's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12178823 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | 12 Nov, 2035 | Active |
| US12343348 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | 12 Nov, 2035 | Active |
| US12419895 | 12 Nov, 2035 | Active | |
| US9757384 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | 12 Nov, 2035 | Active |
| US7799777 | Salts of potassium ATP channel openers and uses thereof | 05 Mar, 2029 | Active |
| US7572789 | Salts of potassium ATP channel openers and uses thereof | 20 Dec, 2026 | Active |
Latest Legal Activities on Soleno's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Soleno.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 11 Sep, 2025 | US12419895 |
| Issue Notification Mailed | 10 Sep, 2025 | US12419895 |
| Dispatch to FDC | 29 Aug, 2025 | US12419895 |
| Application Is Considered Ready for Issue | 29 Aug, 2025 | US12419895 |
| Issue Fee Payment Received | 25 Aug, 2025 | US12419895 |
| Issue Fee Payment Verified | 25 Aug, 2025 | US12419895 |
| Mail Notice of Allowance | 22 Aug, 2025 | US12419895 |
| Notice of Allowance Data Verification Completed | 20 Aug, 2025 | US12419895 |
| Terminal Disclaimer Filed | 07 Aug, 2025 | US12419895 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 07 Aug, 2025 | US12419895 |
| Email Notification | 09 Jul, 2025 | US12419895 |
| Mail Non-Final Rejection | 09 Jul, 2025 | US12419895 |
| Electronic Review | 09 Jul, 2025 | US12419895 |
| Recordation of Patent Grant Mailed | 08 Jul, 2025 | US12343348 |
| Information Disclosure Statement considered | 07 Jul, 2025 | US12419895 |
Soleno's Family Patents
Soleno Drug List
Given below is the complete list of Soleno's drugs and the patents protecting them.
1. Vykat Xr
Vykat Xr is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12178823 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome |
12 Nov, 2035
(9 years from now)
| Active |
| US12343348 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome |
12 Nov, 2035
(9 years from now)
| Active |
| US12419895 |
12 Nov, 2035
(9 years from now)
| Active | |
| US9757384 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome |
12 Nov, 2035
(9 years from now)
| Active |
| US7799777 | Salts of potassium ATP channel openers and uses thereof |
05 Mar, 2029
(2 years from now)
| Active |
| US7572789 | Salts of potassium ATP channel openers and uses thereof |
20 Dec, 2026
(9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vykat Xr's drug page